HOME - The Journal of Precision Medicine

LATEST NEWS

SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics

adminpmls20162022-06-16T20:33:13-05:00June 16th, 2022|

Tempus Announces Research Collaboration with Intermountain Healthcare to Advance Precision Oncology Research

adminpmls20162022-06-16T20:14:04-05:00June 16th, 2022|

Bristol Myers Squibb Elects Deepak L. Bhatt, M.D., M.P.H. to Board of Directors

adminpmls20162022-06-16T20:10:01-05:00June 16th, 2022|

Halo Diagnostics to Offer Genomic Testing Cooperative Genomic Profiling Tests

adminpmls20162022-06-16T20:06:56-05:00June 16th, 2022|

Thermo Fisher Scientific Receives CE-IVD Mark for NGS Aneuploidy Diagnostic Software Workflows

adminpmls20162022-06-16T20:04:58-05:00June 16th, 2022|

Allen Institute, Google Release Multiomic Immunology Research Portal

adminpmls20162022-06-16T17:37:13-05:00June 16th, 2022|

Imagia Canexia Health Garners CE-IVD Mark for Comprehensive Cancer Testing Platform

adminpmls20162022-06-16T17:33:32-05:00June 16th, 2022|

Paige, Janssen Partner on Bladder Cancer Dx

adminpmls20162022-06-16T17:32:07-05:00June 16th, 2022|

Kidney Disease Targets Uncovered in Integrated Omics Analysis

adminpmls20162022-06-16T13:43:55-05:00June 16th, 2022|

SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics - thejournalofprecisionmedicine.com/somalogic-anno…
2 weeks ago
Tempus Announces Research Collaboration with Intermountain Healthcare to Advance Precision Oncology Research - thejournalofprecisionmedicine.com/tempus-announc…
2 weeks ago
Bristol Myers Squibb Elects Deepak L. Bhatt, M.D., M.P.H. to Board of Directors - thejournalofprecisionmedicine.com/bristol-myers-…
2 weeks ago

LATEST ISSUE

The Journal of Precision Medicine - June 2022

The Center for Applied Genomics at The Children’s Hospital of Philadelphia: Perspectives on a Decade with the Electronic Medical Records and Genomics (eMERGE) Consortium

Clinical trials for the management of malignant lymphoma and leukemia

Drugging the Genome with a Novel and Scalable Therapeutic Modality to Address Diseases at the Base Level

The Biomarker to Companion Diagnostic Continuum

Advancing on a path to precision health by revealing the hidden signals in our healthcare data

A Humanistic Goal: Limiting Overtreatment Through Comprehensive Medication Management

A Clinical AI Application to Enable Accurate and Efficient Detection of Breast Cancer Metastases in Lymph Nodes

Proteomics at the heart of multiomic strategies to enable precision medicine

AWS Interoperability and Precision Medicine

Scalable multiplex CRISPR knockouts and a new knock-in research method to support personalized medicine discoveries

The SepSIGN Trial for Early Detection of Sepsis

ARCHIVE ISSUES

March 2022

Articles include:
Applications of Spatial‑Omics in Clinical Translational Cancer Research, Illumina‑SomaLogic Deal to bring together genomics and proteomics technology platforms, How I Learned the Hard Way to Ask Questions About Medications.

Read More

September 2021

Articles include:
The Integration of Personalized Medicine into Healthcare: Advancing the Promise to More Patients, The value of adding RNA sequencing to precision biomarker strategy, As Targeted Therapies Expand Beyond Cancer, Companion Diagnostics Must Improve.

Read More

June 2021

Articles include:
myRabble: A novel patient platform to improve access to personalized medicine, Clinical data and precision medicine: The urgent need for in‑house NGS capabilities at community hospitals.

Read More

March 2021

Articles include:
Integrating biomarker and translational research in a drug development pipeline, Early Detection of Cancer: Transitioning from Emerging to Established Companies and Technologies.

Read More

LATEST NEWS

SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics

Tempus Announces Research Collaboration with Intermountain Healthcare to Advance Precision Oncology Research

Bristol Myers Squibb Elects Deepak L. Bhatt, M.D., M.P.H. to Board of Directors

Halo Diagnostics to Offer Genomic Testing Cooperative Genomic Profiling Tests

Thermo Fisher Scientific Receives CE-IVD Mark for NGS Aneuploidy Diagnostic Software Workflows

Allen Institute, Google Release Multiomic Immunology Research Portal

Imagia Canexia Health Garners CE-IVD Mark for Comprehensive Cancer Testing Platform

Paige, Janssen Partner on Bladder Cancer Dx

Kidney Disease Targets Uncovered in Integrated Omics Analysis

Recent Tweets

LATEST ISSUE

ARCHIVE ISSUES

March 2022

September 2021

June 2021

March 2021

SUBSCRIBE